11119959 · Active · incorporated 8 years, 10 months ago · Cambridge
Biotech Biotech & Life Sciences Drug Discovery Series B+
Amphista Therapeutics develops medicines for hard-to-treat diseases using targeted protein degradation approaches.
Amphista Therapeutics Limited is a private limited company registered at Companies House under number 11119959, incorporated on 20 December 2017, with a registered office in Cambridge. Its current status on the register is active. Its filed nature of business is research and experimental development on biotechnology (SIC 72110). Sonde has indexed 136 filings for this company, including 5 funding rounds. Its most recent round closed in November 2025, raising £12.6m.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 5 | Nov 2025 | £12.6m | £3.00 |
| Round 4 | Dec 2022 | £7.4m | £3.80 |
| Round 3 | Nov 2021 | £14m | £3.00 |
| Round 2 | Mar 2021 | £14m | £3.00 |
| Round 1 | Mar 2020 | £6.7m | £1.00 |
Showing the 11 most recent of 136 filings.
See the complete cap table with every shareholder, founder tags, dilution across 28 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.